A shadow market for unapproved weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Investigational Treatment Acquiring Popularity Online
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these accounts directly for source information, while also receiving discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.
Several professionals said the demand for the experimental drug could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and customer laws, risking penalties, prosecution or prison.
Platform Response and Content Elimination
According to TikTok, the service has removed problematic content and banned associated keywords and query recommendations. The company said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.
Online Trading Activities
Research also found groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of weight loss, positive testimonials and detailed instructions for preparing or injecting at home.
Within moments of joining one group, a vendor shared contact information, where most purchases take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about weight, health issues or previous experience.
Product Details and Costs
Within these groups, posts display dark colored packages with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has already seen patients harmed by personal administration from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject users to potentially significant health risks”.
